胃食管癌-话题@MedSci

#胃食管癌#

8篇内容 | 1406人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183578, encodeId=2d5e21835e86b, content=<a href='/topic/show?id=cbef6022e4c' target=_blank style='color:#2F92EE;'>#曲妥珠单抗#</a> <a href='/topic/show?id=635c8513167' target=_blank style='color:#2F92EE;'>#脑转移#</a> <a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=最大规模研究：HER2+晚期食管/GEJ癌患者脑转移风险高，曲妥珠单抗治疗改善生存, objectType=article, longId=810616, objectId=4c3881061621, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-staff-meeting-GXNVP9J.jpg, objectUrl=/article/show_article.do?id=4c3881061621, replyNumber=0, likeNumber=73, createdTime=2024-01-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=4c3881061621, moduleTitle=最大规模研究：HER2+晚期食管/GEJ癌患者脑转移风险高，曲妥珠单抗治疗改善生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c3881061621)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1483091, encodeId=6df314830914d, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值, objectType=article, longId=738658, objectId=9f99e3865805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f99e3865805, replyNumber=0, likeNumber=81, createdTime=2022-09-10, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f99e3865805, moduleTitle=JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f99e3865805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483090, encodeId=5e461483090a7, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性, objectType=article, longId=216405, objectId=ebbc216405c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebbc216405c0, replyNumber=0, likeNumber=81, createdTime=2021-08-29, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebbc216405c0, moduleTitle=Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebbc216405c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483089, encodeId=40f114830896e, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=Cancers：晚期胃食管癌免疫疗法的生物标志物, objectType=article, longId=211939, objectId=cad621193990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cad621193990, replyNumber=0, likeNumber=84, createdTime=2021-05-29, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cad621193990, moduleTitle=Cancers：晚期胃食管癌免疫疗法的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cad621193990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483088, encodeId=1592148308812, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果, objectType=article, longId=211614, objectId=6cbb211614a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cbb211614a4, replyNumber=0, likeNumber=0, createdTime=2021-05-23, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cbb211614a4, moduleTitle=JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cbb211614a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483087, encodeId=00c0148308eb4, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来, objectType=article, longId=183907, objectId=3dfe18390e65, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfe18390e65, replyNumber=0, likeNumber=73, createdTime=2019-12-03, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfe18390e65, moduleTitle=2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dfe18390e65)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483086, encodeId=03c31483086b4, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=Oncologie宣布与Merck进行临床试验合作，评估Bavituximab与PD-1单抗KEYTRUDA联合治疗晚期胃癌或胃食管癌, objectType=article, longId=177568, objectId=24091e7568e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24091e7568e4, replyNumber=0, likeNumber=65, createdTime=2019-08-15, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24091e7568e4, moduleTitle=Oncologie宣布与Merck进行临床试验合作，评估Bavituximab与PD-1单抗KEYTRUDA联合治疗晚期胃癌或胃食管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24091e7568e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483085, encodeId=89fe1483085b5, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=Lancet Oncol：将单克隆抗体与杀伤细胞药物偶联（DS-8201）治疗晚期乳腺癌、胃食管癌的治疗效果和安全性。, objectType=article, longId=116484, objectId=912e1164841a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=912e1164841a, replyNumber=0, likeNumber=75, createdTime=2017-10-19, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=912e1164841a, moduleTitle=Lancet Oncol：将单克隆抗体与杀伤细胞药物偶联（DS-8201）治疗晚期乳腺癌、胃食管癌的治疗效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=912e1164841a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483084, encodeId=c7f814830840e, content=<a href='/topic/show?id=c294834104a' target=_blank style='color:#2F92EE;'>#胃食管癌#</a>, objectTitle=欧美澳亚四方权威共识——胃食管癌共识组专家访谈, objectType=article, longId=4479, objectId=88e244e920, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88e244e920, replyNumber=0, likeNumber=77, createdTime=2012-04-01, rootId=0, userName=ms1756883563247400, userId=e5da7876937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88e244e920, moduleTitle=欧美澳亚四方权威共识——胃食管癌共识组专家访谈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88e244e920)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胃食管癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#曲妥珠单抗# #脑转移# #胃食管癌#

最大规模研究：HER2+晚期食管/GEJ癌患者脑转移风险高，曲妥珠单抗治疗改善生存

2024-01-24发表于陕西省

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值

2022-09-10

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性

2021-08-29

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

Cancers：晚期胃食管癌免疫疗法的生物标志物

2021-05-29

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果

2021-05-23

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来

2019-12-03

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

Oncologie宣布与Merck进行临床试验合作，评估Bavituximab与PD-1单抗KEYTRUDA联合治疗晚期胃癌或胃食管癌

2019-08-15

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

Lancet Oncol：将单克隆抗体与杀伤细胞药物偶联（DS-8201）治疗晚期乳腺癌、胃食管癌的治疗效果和安全性。

2017-10-19

ms1756883563247400 (审核中...)

前往app查看评论内容

#胃食管癌#

欧美澳亚四方权威共识——胃食管癌共识组专家访谈

2012-04-01

科室
- - 订阅+
  - 更多科室
工具
服务